Welcome to LookChem.com Sign In | Join Free Post buying lead Chemical Tools
Home > Products > 170277-31-3

Detail of "170277-31-3"

  • CAS Number:
  • 170277-31-3
  • Name:
  • Immunoglobulin G,anti-(human tumor necrosis factor) (human-mouse monoclonal cA2 heavy chain),disulfide with human-mouse monoclonal cA2 light chain, dimer

  • Molecular Weight:
  • 0
  • Synonyms:
  • Avakine;Infliximab; Remicade

Famous Chemical Enterprises

  • Livzon
  • Total
  • Shell
  • Dupont
  • Exxonmobil
  • Akzonobel
  • Basf
  • Bayer
  • BP
Please post your buying leads>>
Display:
  • Manufacturer
  • Enterprise Authentication
  • Suppiers of more reward points first
  • New supplier

CAS No.170277-31-3 Immunoglobulin G,anti-(human tumor necrosis factor) (human-mouse monoclonal cA2 heavy chain),disulfide with human-mouse monoclonal cA2 light chain, dimer

Supplier:Hangzhou utanpharma Co., Ltd [ China (Mainland)]

Gold
Supplier
1410Integral
1410

Tel:0571-86821378 ,86820258,56836287,56836288

Address:Block D ,20F, Tianyuan Building,No.508, Wensan RD, 310013,Hangzhou Zhejiang China

Contact Suppliers

CAS No.170277-31-3 Immunoglobulin G, anti-(human tumor necrosis factor) (human-mouse monoclonal cA2 heavy chain), disulfide with human-mouse monoclonal cA2 light chain, dimer

Supplier:St. Martin Commodities [ Select your country]

10Integral
10

Tel:880-2-9555779

Address:47/4, Toyenbee Circular Road, 2nd Floor, Dhaka-1000, Dhaka, Dhaka, Bangladesh 1000

Contact Suppliers

Please post your buying leads,so that our qualified suppliers will soon contact you!
*Required Fields

Reference

Infliximab
Infliximab. Mimori, Tsuneyo (Grad. Sch. Med., Kyoto Univ., Japan). Cardiac Practice, 15(1), 100-102 (Japanese) 2004 Medikaru Rebyusha. CODEN: CARPEM. ISSN: 0915-874X. There are some commonly used reagents like 170277-31-3 in this article. DOCUMENT TYPE: Journal; General Review CA Section: 1 (Pharmacology) A review on infliximab, a chimeric monoclonal antibody to TNFa, for treatment of rheumatoid arthritis, discussing its characteristics, action mechanism, clin. effects, and adverse effects and problems. .
Infliximab
All Rights Reserved. Infliximab. Sekiguchi, Naoya; Takeuchi, Tsutomu (Dep. of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical School, Saitama, Japan). Saishin Igaku, 61(5), 925-931 (Japanese) 2006 Saishin Igakusha. CODEN: SAIGAK. ISSN: 0370-8241. DOCUMENT TYPE: Journal; General Review CA Section: 1 (Pharmacology) Section cross-reference(s): 15 A review, discussing the action mechanism and clin. pharmacol.In this experiment, several chemicals are used like 170277-31-3 of infliximab, a TNF-a antibody, for treatment of rheumatoid arthritis. .
Please post your buying leads
so that our qualified suppliers will soon contact you!

©2008 LookChem.com,License:ICP NO.:Zhejiang10014259

[Hangzhou]86-571-85317600,85317603,85317620